Literature DB >> 24571075

On bacteriocin delivery systems and potential applications.

Timothy D Arthur1, Veronica L Cavera, Michael L Chikindas.   

Abstract

Bacteriocins are antimicrobial peptides produced by a variety of bacteria. These peptides can act as antibiotic synergists or alternatives to enhance the therapeutic effects of current infection treatments and decrease the prevalence of resistant strains. Two bacteriocins, namely nisin and pediocin PA-1, are currently being used by the food industry; however, the introduction of these and others into the biomedical industry, and further development of food applications, have been challenged by the slow development of reliable delivery systems. For bacteriocins, these systems rely on novel and pre-existing technologies. Many essential variables need to be accounted for to formulate successful delivery methods. In this review, documented and potential bacteriocin delivery systems are examined, with special attention paid to how those systems are being implemented in the food and medical industries.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24571075     DOI: 10.2217/fmb.13.148

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  22 in total

1.  In Vivo Assessment of Immunogenicity and Toxicity of the Bacteriocin TSU4 in BALB/c Mice.

Authors:  Tapasa Kumar Sahoo; Prasant Kumar Jena; Bhumika Prajapati; Laxita Gehlot; Amiya Kumar Patel; Sriram Seshadri
Journal:  Probiotics Antimicrob Proteins       Date:  2017-09       Impact factor: 4.609

2.  Probiotics and antimicrobial peptides: the creatures' and substances' future in the twenty-first century: an opinion letter.

Authors:  Michael L Chikindas
Journal:  Probiotics Antimicrob Proteins       Date:  2014-06       Impact factor: 4.609

3.  Biochemical Properties and Mechanism of Action of Enterocin LD3 Purified from Enterococcus hirae LD3.

Authors:  Aabha Gupta; Santosh Kumar Tiwari; Victoria Netrebov; Michael L Chikindas
Journal:  Probiotics Antimicrob Proteins       Date:  2016-09       Impact factor: 4.609

4.  Defining the structure and receptor binding domain of the leaderless bacteriocin LsbB.

Authors:  Kirill V Ovchinnikov; Per E Kristiansen; Gordana Uzelac; Ljubisa Topisirovic; Milan Kojic; Jon Nissen-Meyer; Ingolf F Nes; Dzung B Diep
Journal:  J Biol Chem       Date:  2014-07-03       Impact factor: 5.157

5.  Empirical comparison of web-based antimicrobial peptide prediction tools.

Authors:  Musa Nur Gabere; William Stafford Noble
Journal:  Bioinformatics       Date:  2017-07-01       Impact factor: 6.937

6.  Whole-genome sequencing of mutants with increased resistance against the two-peptide bacteriocin plantaricin JK reveals a putative receptor and potential docking site.

Authors:  Bie Ekblad; Jon Nissen-Meyer; Tom Kristensen
Journal:  PLoS One       Date:  2017-09-20       Impact factor: 3.240

7.  Antimicrobial nisin acts against saliva derived multi-species biofilms without cytotoxicity to human oral cells.

Authors:  Jae M Shin; Islam Ateia; Jefrey R Paulus; Hongrui Liu; J Christopher Fenno; Alexander H Rickard; Yvonne L Kapila
Journal:  Front Microbiol       Date:  2015-06-18       Impact factor: 5.640

8.  Purification and Characterization of Suicin 65, a Novel Class I Type B Lantibiotic Produced by Streptococcus suis.

Authors:  Katy Vaillancourt; Geneviève LeBel; Michel Frenette; Nahuel Fittipaldi; Marcelo Gottschalk; Daniel Grenier
Journal:  PLoS One       Date:  2015-12-28       Impact factor: 3.240

Review 9.  Nanotechnology: A Valuable Strategy to Improve Bacteriocin Formulations.

Authors:  Hazem A Fahim; Ahmed S Khairalla; Ahmed O El-Gendy
Journal:  Front Microbiol       Date:  2016-09-16       Impact factor: 5.640

10.  Pentocin MQ1: A Novel, Broad-Spectrum, Pore-Forming Bacteriocin From Lactobacillus pentosus CS2 With Quorum Sensing Regulatory Mechanism and Biopreservative Potential.

Authors:  Samson B Wayah; Koshy Philip
Journal:  Front Microbiol       Date:  2018-03-27       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.